Sir Patrick Stewart, the renowned actor, passed away yesterday at the age of 86 after a brief struggle with Alzheimer’s disease and Lewy Body Dementia. He spent his final moments at home, surrounded by live music, prayer, and laughter, with the support of his devoted wife, Sunny. Stewart was born in West Riding of Yorkshire and had a distinguished acting career that lasted six decades. He won two Laurence Olivier Awards for his performances in supporting roles in Antony and Cleopatra and Hamlet.
Stewart’s most iconic role was that of Captain Jean-Luc Picard in Star Trek: The Next Generation, which he reprised in four films from 1994 to 2002. Initially, Stewart was not a well-known figure, and he had concerns about whether audiences would connect with him as a bald, middle-aged English Shakespearean actor. Producer Robert Justman noted that Stewart had a remarkable way of speaking that made his performances more captivating.
Stewart also gained fame for his role as Professor X in the X-Men series, where he acted alongside his close friend Ian McKellen, who portrayed Magneto. McKellen shared a heartfelt tribute, describing Stewart as a trustworthy and admirable person. He recalled a moment when Stewart considered a role in Star Trek and wondered if it might overshadow his stage career in the UK, expressing gratitude that Stewart decided to take that chance.
Despite becoming a star in America, Stewart maintained his connection to his roots in England. He was especially proud of being appointed Chancellor of Huddersfield University in Yorkshire. In a statement from Stewart’s family, they mentioned that, instead of flowers, donations could be made to the Johns Hopkins Alzheimer’s Disease Research Center Fund and the Alzheimer’s Foundation of America Caregiver Resources, reflecting his experiences with the diseases.
The Alzheimer’s Research Center at Johns Hopkins focuses on understanding the early stages and lifestyle treatments that may help manage symptoms and improve care outcomes. Recent advancements include the approval of a blood test designed to detect beta-amyloid, which has been suspected as a major cause of Alzheimer’s. This new test is less invasive and more affordable than traditional methods. The center is also conducting various studies, including one that explores whether treatments for Alzheimer’s can delay the progression to mild cognitive impairment in individuals at risk. Another study aims to see if existing medications can be effective against Frontotemporal Dementia.
Sources:
Source: Good News Network, by Andy Corbley